PAMUKÇUOĞLU, M. Et Al. 2021. The Comparison of the Biosimilar Filgrastim (Tevagrastim) and the Original Filgrastim (Neupogen) in the Autologous Hematopoetic Stem Cell Mobilization: A Single Center Experience. Acta Oncologica Turcica .

PAMUKÇUOĞLU, M., GÜNEŞ, A. K., UÇAR, M. A., CERAN, F., FALAY, M., ÖZET, G., ... DAĞDAŞ, S.(2021). The Comparison of the Biosimilar Filgrastim (Tevagrastim) and the Original Filgrastim (Neupogen) in the Autologous Hematopoetic Stem Cell Mobilization: A Single Center Experience. Acta Oncologica Turcica .

PAMUKÇUOĞLU, MERVE Et Al. "The Comparison of the Biosimilar Filgrastim (Tevagrastim) and the Original Filgrastim (Neupogen) in the Autologous Hematopoetic Stem Cell Mobilization: A Single Center Experience," Acta Oncologica Turcica , 2021

PAMUKÇUOĞLU, MERVE Et Al. "The Comparison of the Biosimilar Filgrastim (Tevagrastim) and the Original Filgrastim (Neupogen) in the Autologous Hematopoetic Stem Cell Mobilization: A Single Center Experience." Acta Oncologica Turcica , 2021

PAMUKÇUOĞLU, M. Et Al. (2021) . "The Comparison of the Biosimilar Filgrastim (Tevagrastim) and the Original Filgrastim (Neupogen) in the Autologous Hematopoetic Stem Cell Mobilization: A Single Center Experience." Acta Oncologica Turcica .

@article{article, author={MERVE PAMUKÇUOĞLU Et Al. }, title={The Comparison of the Biosimilar Filgrastim (Tevagrastim) and the Original Filgrastim (Neupogen) in the Autologous Hematopoetic Stem Cell Mobilization: A Single Center Experience}, journal={Acta Oncologica Turcica}, year=2021}